Universal Coronavirus & Influenza Vaccines: Osivax secures funding
by Press Release from Outbreak News Today on (#55JPZ)
Osivax announced today that it has received over EUR 30M in public funding from different sources to support the development of universal vaccines against coronavirus and influenza. The Company's proprietary oligoDOM(R) technology enables the development of vaccines that aim to protect the body from all viral influenza strains. By targeting the nucleoprotein, a highly conserved antigen with [...]
The post Universal Coronavirus & Influenza Vaccines: Osivax secures funding appeared first on Outbreak News Today.